Subchronic use of rivastigmine increases procognitive flexibility across multimodal behavioral tasks in healthy male rats

dc.contributor.authorHormigo, Sebastian
dc.contributor.authorRodríguez Lorenzana, Alberto
dc.contributor.authorCastro-Salazar, E.
dc.contributor.authorMillian Morell, Lymarie
dc.contributor.authorLópez, Dolores E.
dc.contributor.departmentCiencias de la Saludes_ES
dc.contributor.departmentOsasun Zientziakeu
dc.date.accessioned2024-02-06T17:18:10Z
dc.date.available2024-02-06T17:18:10Z
dc.date.issued2019
dc.date.updated2024-02-06T12:19:33Z
dc.description.abstractRivastigmine (RVT) is a reversible inhibitor of cholinesterase approved worldwide for the treatment of cognitive dysfunctions, especially in Alzheimer's disease. Most previous pre-clinical studies have examined the effects of RVT treatment in a wide variety of pathological research models. Nonetheless, the effects of this drug on sensorimotor gating, memory, and learning tasks in healthy subjects remains unclear. In this study, we investigate the procognitive effects of RVT treatment in healthy rats through sensorimotor gating evaluations (measured as prepulse inhibition of the acoustic startle reflex), active avoidance learning, and spatial memory learning in a radial maze. There is an increase in the amplitude of the startle reflex in RVT-treated rats compared to the control groups, whereas the latency remained constant. Sensorimotor gating values were also incremented compared to those values from controls. In active avoidance, rats treated with RVT learned faster to successfully perform the task compared to controls, but afterwards all groups exhibited virtually identical results. During the sessions in the radial maze, RVT-treated rats committed fewer errors in both the working and reference memory compared to controls. All in all, our results support the hypothesis that RVT treatment may entail procognitive effects in healthy subjects.en
dc.description.sponsorshipThis study was supported in part by Spanish grants SAF2016-78898-C2-2R (MINECO) and by the University of Salamanca Research Support Grant for GIRs 2018. E. C.-S. was supported by a Master Research Scholarship from Ministerio de Educación Superior Ciencia y Tecnología de la República Dominicana (MESCyT).en
dc.format.mimetypeapplication/pdfen
dc.identifier.citationHormigo, S., Rodriguez-Lorenzana, A., Castro-Salazar, E., Millian-Morell, L., López, D. E. (2019) Subchronic use of rivastigmine increases procognitive flexibility across multimodal behavioral tasks in healthy male rats. Behavioural Brain Research, 376, 1-9. https://doi.org/10.1016/j.bbr.2019.112077.en
dc.identifier.doi10.1016/j.bbr.2019.112077
dc.identifier.issn0166-4328
dc.identifier.urihttps://academica-e.unavarra.es/handle/2454/47337
dc.language.isoengen
dc.publisherElsevieren
dc.relation.ispartofBehavioural Brain Research 376 (2019) 11207en
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//SAF2016-78898-C2-2R/
dc.relation.publisherversionhttps://doi.org/10.1016/j.bbr.2019.112077
dc.rights© 2019 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0en
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAcetylcholinesteraseen
dc.subjectActive avoidanceen
dc.subjectPrepulse inhibitionen
dc.subjectRadial mazeen
dc.subjectSensorimotor gatingen
dc.subjectStartle reflexen
dc.titleSubchronic use of rivastigmine increases procognitive flexibility across multimodal behavioral tasks in healthy male ratsen
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dspace.entity.typePublication
relation.isAuthorOfPublication5d4af467-7d54-453e-94d0-d39d7c76369a
relation.isAuthorOfPublication.latestForDiscovery5d4af467-7d54-453e-94d0-d39d7c76369a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Hormigo_SubchronicUse.pdf
Size:
898.71 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.78 KB
Format:
Item-specific license agreed to upon submission
Description: